Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$718M |
| 2 |
Microsoft
MSFT
|
+$662M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$404M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$709M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 5 |
Home Depot
HD
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.54% |
| 2 | Healthcare | 5.02% |
| 3 | Consumer Discretionary | 4.7% |
| 4 | Financials | 4.22% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
Intercontinental Exchange
ICE
$85.6B
| $1.36M | ﹤0.01% |
+12,000
| New | +$1.3M |
|
2527
US Physical Therapy
USPH
$1.2B
| $1.36M | ﹤0.01% |
11,175
+4,611
| +70% | +$497K |
|
2528
Duolingo
DUOL
$6.28B
| $1.36M | ﹤0.01% |
9,490
+8,089
| +577% | +$1.16M |
|
2529
Minerals Technologies
MTX
$2.36B
| $1.36M | ﹤0.01% |
23,496
+8,752
| +59% | +$509K |
|
|
VISN
2530
Vistance Networks Inc
VISN
$2.65B
| $1.36M | ﹤0.01% |
240,716
+146,050
| +154% | +$698K |
|
2531
iShares Core Universal USD Bond ETF
IUSB
$42.9B
| $1.35M | ﹤0.01% |
29,793
+839
| +3% | +$38.4K |
|
2532
PVH
PVH
$4B
| $1.35M | ﹤0.01% |
15,928
-2,357
| -13% | -$199K |
|
|
WCC
2533
WESCO International
WCC
$16.7B
| $1.35M | ﹤0.01% |
7,541
+2,945
| +64% | +$429K |
|
2534
MGE Energy Inc
MGEE
$3B
| $1.35M | ﹤0.01% |
17,062
+15,899
| +1,367% | +$1.22M |
|
2535
Sensient Technologies
SXT
$5.26B
| $1.34M | ﹤0.01% |
18,862
-54,858
| -74% | -$4.07M |
|
2536
Hamilton Lane
HLNE
$4.91B
| $1.34M | ﹤0.01% |
16,765
+14,938
| +818% | +$1.07M |
|
2537
Gildan
GIL
$10.3B
| $1.34M | ﹤0.01% |
41,444
-5,423
| -12% | -$166K |
|
2538
Chemours
CC
$2.5B
| $1.34M | ﹤0.01% |
36,227
+1,615
| +5% | +$49.3K |
|
2539
MGP Ingredients
MGPI
$379M
| $1.34M | ﹤0.01% |
12,571
+4,767
| +61% | +$476K |
|
2540
Certara
CERT
$1.26B
| $1.33M | ﹤0.01% |
73,220
+5,261
| +8% | +$111K |
|
2541
Interactive Brokers
IBKR
$39.2B
| $1.33M | ﹤0.01% |
64,168
+20,284
| +46% | +$400K |
|
2542
Invesco S&P MidCap Value with Momentum ETF
XMVM
$502M
| $1.33M | ﹤0.01% |
28,894
+2,583
| +10% | +$111K |
|
2543
Cinemark Holdings
CNK
$4.24B
| $1.33M | ﹤0.01% |
80,634
-5,768
| -7% | -$95.9K |
|
2544
OneMain Financial
OMF
$7.23B
| $1.33M | ﹤0.01% |
30,414
+2,741
| +10% | +$107K |
|
2545
Enerpac Tool Group
EPAC
$1.83B
| $1.33M | ﹤0.01% |
49,145
+17,962
| +58% | +$456K |
|
2546
CALL
TG Therapeutics
TGTX
$7.96B
| $1.33M | ﹤0.01% |
+53,400
| New | +$1.38M |
|
2547
StoneX
SNEX
$9.26B
| $1.33M | ﹤0.01% |
80,803
+26,624
| +49% | +$475K |
|
2548
Acadia Healthcare
ACHC
$2.76B
| $1.33M | ﹤0.01% |
16,644
-3,839
| -19% | -$277K |
|
2549
Mercury Systems
MRCY
$5.83B
| $1.32M | ﹤0.01% |
38,298
-13,666
| -26% | -$584K |
|
2550
Recursion Pharmaceuticals
RXRX
$1.59B
| $1.32M | ﹤0.01% |
177,338
-510,887
| -74% | -$3.57M |
|
Similar funds
Citigroup's Q2 2023 Portfolio in Review
As of Q2 2023, Citigroup held 5,906 positions worth $153B, up 6.9% from $143B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup's Q2 2023 filing shows 463 new, 2,756 increased, 1,590 reduced and 354 closed positions. Its largest new stake was Vesta Real Estate: 3,353,619 shares worth $108M. The largest sale was iShares Russell 2000 ETF, an estimated $713M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q2 2023 buy was Vesta Real Estate: 3,353,619 shares worth $108M.
- Citigroup added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $718M increase.
- Citigroup's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited DCP Midstream, LP in Q2 2023, selling an estimated $198M.
- Citigroup's ten largest holdings make up 34% of its $153B portfolio in Q2 2023.
- Citigroup opened 463 new positions and closed 354 in Q2 2023.
- Citigroup's portfolio value rose 6.9% quarter-over-quarter to $153B.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.